Cell Based Assays Market
Cell Based Assays Market Forecasts to 2032 - Global Analysis By Product (Reagents, Assay Kits, Microplates, Probes & Labels and Other Products), Type, Technology, Application, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $19.7 BN |
|
Projected Year Value (2032) |
US $39.6 BN |
|
CAGR (2025-2032) |
10.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Cell Based Assays Market is accounted for $19.7 billion in 2025 and is expected to reach $39.6 billion by 2032 growing at a CAGR of 10.5% during the forecast period. Cell-based assays are experimental methods used to study the effects of various substances on living cells. These assays measure cellular responses such as viability, proliferation, cytotoxicity, gene expression, or signal transduction, providing insights into cellular function and biological activity. Commonly used in drug discovery, toxicology, and biomedical research, cell-based assays offer a more physiologically relevant model compared to biochemical assays, as they account for complex cellular processes and interactions. They can be performed using various cell types, including primary cells or cell lines, and often employ imaging, luminescence, fluorescence, or colorimetric techniques to quantify responses.
According to a report released by the American Heart Association in January 2022, every 40 seconds a person gets diagnosed with myocardial infarction in the U.S.
Market Dynamics:
Driver:
Rising demand for biologics and biosimilars
The rising demand for biologics and biosimilars is significantly propelling the cell-based assays market. As these advanced therapeutics require robust efficacy and safety testing, cell-based assays offer precise, physiologically relevant insights during drug development. This growing need accelerates innovation in assay technologies, enhancing throughput and reliability. Pharmaceutical and biotech companies increasingly rely on these assays to streamline research and regulatory compliance. Consequently, the expanding biologics pipeline directly drives sustained growth and investment in the global cell-based assays market.
Restraint:
High cost of instruments and maintenance
The high cost of instruments and ongoing maintenance significantly hinders the growth of the cell-based assays market. These expenses limit adoption, especially among smaller laboratories and research institutions with constrained budgets. Financial barriers restrict access to advanced technologies, slow research progress, and reduce the scalability of operations. Consequently, the market faces slower expansion, limited innovation, and reduced competitiveness, particularly in developing regions where funding is often inadequate.
Opportunity:
Technological Advancements
Technological advancements are positively transforming the cell-based assays market by enhancing assay sensitivity, accuracy, and throughput. Innovations such as automated platforms, high-content screening, and 3D cell culture systems enable faster drug discovery and more predictive in vitro testing. Integration of AI and machine learning further streamlines data analysis, reducing time and cost. These advancements support precision medicine and increase the reliability of results, driving significant growth and adoption across pharmaceutical, biotechnology, and academic research sectors.
Threat:
Complex regulatory frameworks
Complex regulatory frameworks hinder the Cell Based Assays market by causing delays in product approvals, increasing compliance costs, and creating uncertainty for developers. Stringent and varying global regulations slow innovation and limit market entry, especially for smaller companies. These challenges reduce investment incentives and complicate scaling of new assays, ultimately restricting market growth and accessibility of advanced cell-based diagnostic and therapeutic tools.
Covid-19 Impact
The Covid-19 pandemic significantly accelerated the growth of the cell-based assays market due to increased demand for vaccine development, drug screening, and diagnostic testing. Laboratories worldwide expanded research on antiviral drugs and immune responses, driving higher adoption of advanced assay technologies. However, initial lockdowns disrupted supply chains and delayed non-Covid research. Overall, the pandemic boosted innovation and funding in cell-based assays, positioning the market for sustained post-pandemic growth.
The cell viability assay segment is expected to be the largest during the forecast period
The cell viability assay segment is expected to account for the largest market share during the forecast period as it enabling precise measurement of living cells, it ensures accurate evaluation of drug efficacy and toxicity, accelerating drug discovery and development. This segment's rising demand is fueled by its application in cancer research, regenerative medicine, and personalized therapies. Advances in assay technologies enhance sensitivity and throughput, making cell viability assays indispensable for biomedical research and pharmaceutical industries, thereby significantly boosting market expansion.
The drug discovery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the drug discovery segment is predicted to witness the highest growth rate, due to demand for innovative and precise testing methods. As pharmaceutical companies prioritize developing safer, more effective therapies, cell-based assays offer critical insights into drug efficacy and toxicity early in the pipeline. This accelerates R&D timelines, reduces costs, and improves success rates. Consequently, the expanding drug discovery sector propels advancements and adoption of cell-based assays, positively impacting market expansion and technological innovation.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to growing investments in healthcare infrastructure and rising demand for personalized medicine are fueling innovation. These assays enable more accurate drug screening and toxicity testing, improving patient outcomes and accelerating drug discovery. Additionally, increasing awareness and government support in countries like China, India, and Japan are boosting market growth, fostering economic development, and positioning the region as a global hub for cutting-edge biotechnological research.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, as advanced assays enable precise analysis of cellular responses, improving disease modeling and toxicity testing. This fosters innovation in biotechnology and pharmaceuticals, enhancing treatment effectiveness and patient outcomes. The region’s strong R&D infrastructure and growing adoption of automated technologies further boost market growth, creating new job opportunities and supporting healthcare advancements. Overall, it strengthens North America’s leadership in life sciences and healthcare innovation.
Key players in the market
Some of the key players profiled in the Cell Based Assays Market include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Promega Corporation, Lonza Group AG, Agilent Technologies, Charles River Laboratories, Corning Incorporated, GE Healthcare, Sartorius AG, Eurofins Scientific, CytoSMART Technologies, Cell Signaling Technology, Miltenyi Biotec and Abcam plc.
Key Developments:
In April 2025, GE HealthCare and FPT Corporation have expanded their strategic partnership to accelerate AI-driven healthcare innovation. This collaboration includes the establishment of an FPT Competency Center in Vietnam, aimed at enhancing product strategy, development, and customer onboarding within GE HealthCare’s digital ecosystem.
In March 2025, NVIDIA and GE HealthCare have announced a collaboration to advance autonomous diagnostic imaging, focusing on developing AI-driven X-ray and ultrasound technologies. This partnership aims to address the global shortage of radiology professionals and improve access to medical imaging services.
In January 2025, Sutter Health and GE HealthCare have entered into a seven-year strategic partnership, known as the ""Care Alliance,"" aimed at enhancing diagnostic imaging services across California.
Products Covered:
• Reagents
• Assay Kits
• Microplates
• Probes & Labels
• Instruments & Software
• Cell Lines
• Other Products
Types Covered:
• Cell Viability Assay
• Cytotoxicity Assay
• Cell Death Assay
• Cell Proliferation Assay
• Other Types
Technologies Covered:
• Automated Handling
• Flow Cytometry
• High-Throughput Screening (HTS)
• Label-Free Detection
• Other Technologies
Applications Covered:
• Drug Discovery
• Basic Research
• ADME Studies
• Predictive Toxicology
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Academic & Government Research Institutes
• Contract Research Organizations (CROs)
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cell Based Assays Market, By Product
5.1 Introduction
5.2 Reagents
5.3 Assay Kits
5.4 Microplates
5.5 Probes & Labels
5.6 Instruments & Software
5.7 Cell Lines
5.8 Other Products
6 Global Cell Based Assays Market, By Type
6.1 Introduction
6.2 Cell Viability Assay
6.3 Cytotoxicity Assay
6.4 Cell Death Assay
6.5 Cell Proliferation Assay
6.6 Other Types
7 Global Cell Based Assays Market, By Technology
7.1 Introduction
7.2 Automated Handling
7.3 Flow Cytometry
7.4 High-Throughput Screening (HTS)
7.5 Label-Free Detection
7.6 Other Technologies
8 Global Cell Based Assays Market, By Application
8.1 Introduction
8.2 Drug Discovery
8.3 Basic Research
8.4 ADME Studies
8.5 Predictive Toxicology
8.6 Other Applications
9 Global Cell Based Assays Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Government Research Institutes
9.4 Contract Research Organizations (CROs)
9.5 Other End Users
10 Global Cell Based Assays Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Thermo Fisher Scientific
12.2 Danaher Corporation
12.3 Becton, Dickinson and Company (BD)
12.4 Merck KGaA
12.5 PerkinElmer Inc.
12.6 Bio-Rad Laboratories
12.7 Promega Corporation
12.8 Lonza Group AG
12.9 Agilent Technologies
12.10 Charles River Laboratories
12.11 Corning Incorporated
12.12 GE Healthcare
12.13 Sartorius AG
12.14 Eurofins Scientific
12.15 CytoSMART Technologies
12.16 Cell Signaling Technology
12.17 Miltenyi Biotec
12.18 Abcam plc
List of Tables
1 Global Cell Based Assays Market Outlook, By Region (2024-2032) ($MN)
2 Global Cell Based Assays Market Outlook, By Product (2024-2032) ($MN)
3 Global Cell Based Assays Market Outlook, By Reagents (2024-2032) ($MN)
4 Global Cell Based Assays Market Outlook, By Assay Kits (2024-2032) ($MN)
5 Global Cell Based Assays Market Outlook, By Microplates (2024-2032) ($MN)
6 Global Cell Based Assays Market Outlook, By Probes & Labels (2024-2032) ($MN)
7 Global Cell Based Assays Market Outlook, By Instruments & Software (2024-2032) ($MN)
8 Global Cell Based Assays Market Outlook, By Cell Lines (2024-2032) ($MN)
9 Global Cell Based Assays Market Outlook, By Other Products (2024-2032) ($MN)
10 Global Cell Based Assays Market Outlook, By Type (2024-2032) ($MN)
11 Global Cell Based Assays Market Outlook, By Cell Viability Assay (2024-2032) ($MN)
12 Global Cell Based Assays Market Outlook, By Cytotoxicity Assay (2024-2032) ($MN)
13 Global Cell Based Assays Market Outlook, By Cell Death Assay (2024-2032) ($MN)
14 Global Cell Based Assays Market Outlook, By Cell Proliferation Assay (2024-2032) ($MN)
15 Global Cell Based Assays Market Outlook, By Other Types (2024-2032) ($MN)
16 Global Cell Based Assays Market Outlook, By Technology (2024-2032) ($MN)
17 Global Cell Based Assays Market Outlook, By Automated Handling (2024-2032) ($MN)
18 Global Cell Based Assays Market Outlook, By Flow Cytometry (2024-2032) ($MN)
19 Global Cell Based Assays Market Outlook, By High-Throughput Screening (HTS) (2024-2032) ($MN)
20 Global Cell Based Assays Market Outlook, By Label-Free Detection (2024-2032) ($MN)
21 Global Cell Based Assays Market Outlook, By Other Technologies (2024-2032) ($MN)
22 Global Cell Based Assays Market Outlook, By Application (2024-2032) ($MN)
23 Global Cell Based Assays Market Outlook, By Drug Discovery (2024-2032) ($MN)
24 Global Cell Based Assays Market Outlook, By Basic Research (2024-2032) ($MN)
25 Global Cell Based Assays Market Outlook, By ADME Studies (2024-2032) ($MN)
26 Global Cell Based Assays Market Outlook, By Predictive Toxicology (2024-2032) ($MN)
27 Global Cell Based Assays Market Outlook, By Other Applications (2024-2032) ($MN)
28 Global Cell Based Assays Market Outlook, By End User (2024-2032) ($MN)
29 Global Cell Based Assays Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
30 Global Cell Based Assays Market Outlook, By Academic & Government Research Institutes (2024-2032) ($MN)
31 Global Cell Based Assays Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
32 Global Cell Based Assays Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
